12-121327184-A-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 1P and 6B. PP2BP4_ModerateBS2
The NM_016237.5(ANAPC5):āc.1352T>Cā(p.Leu451Pro) variant causes a missense change. The variant allele was found at a frequency of 0.0000248 in 1,613,656 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00015 ( 0 hom., cov: 32)
Exomes š: 0.000012 ( 0 hom. )
Consequence
ANAPC5
NM_016237.5 missense
NM_016237.5 missense
Scores
2
2
15
Clinical Significance
Conservation
PhyloP100: 6.61
Genes affected
ANAPC5 (HGNC:15713): (anaphase promoting complex subunit 5) This gene encodes a tetratricopeptide repeat-containing component of the anaphase promoting complex/cyclosome (APC/C), a large E3 ubiquitin ligase that controls cell cycle progression by targeting a number of cell cycle regulators such as B-type cyclins for 26S proteasome-mediated degradation through ubiquitination. The encoded protein is required for the proper ubiquitination function of APC/C and for the interaction of APC/C with transcription coactivators. It also interacts with polyA binding protein and represses internal ribosome entry site-mediated translation. Multiple transcript variants encoding different isoforms have been found for this gene. These differences cause translation initiation at a downstream AUG and result in a shorter protein (isoform b), compared to isoform a. [provided by RefSeq, Nov 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), ANAPC5. . Gene score misZ 2.2973 (greater than the threshold 3.09). Trascript score misZ 3.2965 (greater than threshold 3.09). GenCC has associacion of gene with schizophrenia.
BP4
Computational evidence support a benign effect (MetaRNN=0.08905253).
BS2
High AC in GnomAd4 at 23 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ANAPC5 | NM_016237.5 | c.1352T>C | p.Leu451Pro | missense_variant | 11/17 | ENST00000261819.8 | NP_057321.2 | |
ANAPC5 | NM_001330489.2 | c.1313T>C | p.Leu438Pro | missense_variant | 11/17 | NP_001317418.1 | ||
ANAPC5 | NM_001137559.1 | c.1016T>C | p.Leu339Pro | missense_variant | 11/17 | NP_001131031.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ANAPC5 | ENST00000261819.8 | c.1352T>C | p.Leu451Pro | missense_variant | 11/17 | 1 | NM_016237.5 | ENSP00000261819 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000151 AC: 23AN: 152256Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
23
AN:
152256
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000399 AC: 10AN: 250720Hom.: 0 AF XY: 0.00000738 AC XY: 1AN XY: 135566
GnomAD3 exomes
AF:
AC:
10
AN:
250720
Hom.:
AF XY:
AC XY:
1
AN XY:
135566
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000116 AC: 17AN: 1461282Hom.: 0 Cov.: 31 AF XY: 0.00000963 AC XY: 7AN XY: 726958
GnomAD4 exome
AF:
AC:
17
AN:
1461282
Hom.:
Cov.:
31
AF XY:
AC XY:
7
AN XY:
726958
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000151 AC: 23AN: 152374Hom.: 0 Cov.: 32 AF XY: 0.000134 AC XY: 10AN XY: 74518
GnomAD4 genome
AF:
AC:
23
AN:
152374
Hom.:
Cov.:
32
AF XY:
AC XY:
10
AN XY:
74518
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
3
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
9
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 23, 2024 | The c.1352T>C (p.L451P) alteration is located in exon 11 (coding exon 11) of the ANAPC5 gene. This alteration results from a T to C substitution at nucleotide position 1352, causing the leucine (L) at amino acid position 451 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
.;T;T;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Pathogenic
D
LIST_S2
Benign
T;T;T;T
M_CAP
Benign
T
MetaRNN
Benign
T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;.;M;.
MutationTaster
Benign
D;D;D;D;D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;N;N
REVEL
Benign
Sift
Benign
T;T;T;T
Sift4G
Pathogenic
D;D;D;D
Polyphen
0.0080, 0.0030
.;.;B;B
Vest4
MVP
MPC
1.1
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at